LAURA RITCHIE: Open Payments
NPI 1376264069 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,857 in 41 payments from 11 companies in 2025. Trend: 2023 $887 · 2024 $1,482 · 2025 $2,857
Food & beverage: $1,937Consulting: $920
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 14 | $1,409 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $443 |
| ABBVIE INC. | 7 | $328 |
| Novo Nordisk Inc | 5 | $270 |
| Ipsen Biopharmaceuticals, Inc | 2 | $184 |
| Madrigal Pharmaceuticals | 3 | $84 |
| Mallinckrodt Hospital Products Inc. | 1 | $58 |
| Mirum Pharmaceuticals, Inc. | 1 | $25 |
| Intercept Pharmaceuticals, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: Livdelzi, XIFAXAN, MAVYRET, IQIRVO, Wegovy, REZDIFFRA, TERLIVAZ, Livmarli.
Industry payments across IL — which companies pay providers there.
